| |
|
|
|
|
|
|
|||
|
IMMUNOBIOLOGY
From the Dendritic Cell Laboratory, Mater Medical
Research Institute; University of Queensland Department of Surgery,
Mater Misericordiae Hospitals Campus; and Clinical Epidemiology Centre,
Mater Misericordiae Hospitals; all of Brisbane, Australia.
Dendritic cells (DCs) are specialized antigen-presenting cells that
have the unique ability to initiate a primary immune response. The
effect of physiologic stress on circulating blood DCs has thus far not
been studied. In this study, we applied a recently developed method of
counting blood DCs to test the hypothesis that significant stress to
the body such as surgery and exercise might induce measurable changes
in the DC numbers, subsets, phenotype, and function. Twenty-six
patients scheduled for elective laparoscopic cholecystectomy, 4 for elective hysterectomy, 56 controls, and 5 volunteers who underwent
a stress exercise test were enrolled in the study. Absolute DC
counts increased acutely (71.7% ± 11% [SEM],
P = .0001) in response to the stress of surgery and
dropped below preoperative levels ( Dendritic cells (DCs) are the key specialist
antigen-presenting cells that initiate and direct immune
responses.1,2 They are produced in the bone marrow,
circulate via the blood, and enter the body tissues and mucosal
surfaces to act as immune sentinels. When tissues are damaged by trauma
or infection or are altered by malignant transformation, inflammatory
cytokines and other cellular products are released. These stimuli,
whether from the tissues (endogenous) or from microbial products
(exogenous), activate resident DCs and also promote recruitment of
circulating DCs to the site.3 DCs actively capture and
process antigens and then migrate via the lymphatics to draining nodes.
Here, they present processed antigens to T and B lymphocytes to
initiate primary or stimulate secondary (memory) immune responses. As
such, they play a central role in immune surveillance, an essential
part of the defense and protective mechanism against infections and malignancy.4
Surgical stress as a result of tissue injury and exposure to
anesthesia evokes alterations in metabolic, immune, and endocrine functions.4,5 Endogenous secretion of glucocorticoids and catecholamines can be measured by a rise in serum cortisol, adrenaline, and noradrenaline. Damaged tissues release inflammatory cytokines, which include interleukin 1 Circulating DCs are scarce and represent less than 1% of peripheral
blood mononuclear cells.2,9 They fall within the lineage-negative (Lin We hypothesized that a significant physiologic stress such as that
induced by surgery or exercise would result in measurable changes in
peripheral blood DC counts. This study monitored the changes in DC
counts in patients undergoing a standard surgical procedure and
exercise and related these changes to other leukocyte counts.
Study subjects
Study design
Each control individual provided blood samples for DC counts at time points that were representative of the times when the surgical patients typically had their samples collected. The PreAdm sample was collected at noon. The samples on the day of surgery were collected at 8 AM, 12 PM, and 2 PM to correspond to the PreOp, IntraOp, and Recovery times, respectively. All subsequent collections were between 8 AM and 9 AM. All other healthy volunteers provided blood samples between 8 AM and 9 AM. Volunteers performing the treadmill exercise test had blood samples collected prior to (PreEx), immediately after (PostEx 0 hours), and 2 hours (PostEx 2 hours) and 4 hours (PostEx 4 hours) after the exercise and the following day. Heart rate, blood pressure, and continuous 12-lead electrocardiogram measurements were taken throughout the procedure. Blood DC counting assay The method of blood DC counting using the CMRF-44 mAb and flow cytometry has been described elsewhere.9 Briefly, 4 mL blood was collected into a standard ethylenediaminetetraacetic acid blood tube. Mononuclear cells (MNCs) were isolated by Ficoll-Hypaque density gradient centrifugation and cultured in U-bottom tubes for 16 to 24 hours in RPMI 1640/10% fetal calf serum at 37°C and 5% CO2 to allow for the maximal up-regulation of the CMRF-44 antigen on DCs.9 Using standard immunolabeling technique, cells were incubated sequentially with the CMRF-44 mAb and fluorescein isothiocyanate-conjugated sheep antimouse immunoglobulin (FITC-SAM). After blocking with 10% mouse serum, phycoerythrin (PE)-conjugated CD14 and CD19 mAb were added. Propidium iodide (PI) was added, and cells were analyzed using a FACSVantage flow cytometer (Becton Dickinson, San Jose, CA). Live MNCs were gated on forward and side light-scatter characteristics (Figure 1A, left) and PI exclusion. DCs were defined as CMRF-44+ CD14 CD19 events (Figure 1A, right).
Absolute DC counts (106/L) were calculated from the number
of MNCs per liter of blood (as determined by the automated cell
counter) multiplied by the percentage of DCs (mean of triplicates). Any
adherent cells detached from the tube after vigorous 2 mM
ethylenediaminetetraacetic acid/phosphate-buffered saline pipetting
were negligible (< 1000 cells or 0.01% of the original cell number
recovered) and, when analyzed, fell outside the Lin
HLA-DR+ gate (data not shown). In some experiments, fresh
MNCs were also used.
Analysis of DC phenotype, activation, costimulatory molecules, and subsets Three-color flow cytometry was performed for the following analyses. To determine immunophenotype of the CMRF-44+ DCs, cultured MNCs were stained with biotinylated CMRF-44 mAb followed by PE-cyanin 5-conjugated streptavidin, and FITC-conjugated mAb, specific for CD14 and CD19 in combination with PE-conjugated mAb specific for HLA-DR, CD4, CD40, CD80, CD83, CD86, CD11c, and CD123. For the analysis of the expression of DC activation and costimulatory molecules, fresh MNCs were used. MNCs were first stained with specific lineage marker mAb, CD3, CD14, CD16, and CD19, followed by FITC-SAM. After blocking with 10% mouse serum, the cells were stained with PE-cyanin 5-conjugated HLA-DR mAb and PE-conjugated CD40, CD86, and CD11c.In a separate experiment, MNCs were pretreated with media containing
hydrocortisone (10 Clinical measurements Full differential blood count measurements were performed using automated counters Advia 120, Haematology System, or Technicon H.3 RTX (Bayer, Tarrytown, NY) used for routine clinical analyses at the Mater Adult Hospital. Serum cortisol was measured using fluorescence polarization immunoassay (Abbott TDx, Abbott Laboratories, Abbott Park, IL).Allogeneic mixed leukocyte reaction The ability of MNCs (with different DC numbers) isolated at the various time points perioperatively to stimulate purified allogeneic T lymphocytes was tested in a mixed leukocyte reaction (MLR). A titration of patient MNCs (5 × 103 to 3 × 105 cells) was incubated with T lymphocytes (5 × 104 cells) for 5 days in 96-well U-bottom plates. Sixteen hours prior to harvesting the cells, 18.5 kBq of 3H-thymidine was added to each well. Then, 3H-thymidine uptake was counted in a liquid -scintillation counter (MicroBeta Trilux Scintillation
Counter, Wallac, Turku, Finland).
Monoclonal antibodies and reagents The following monoclonal antibodies were used: unconjugated and biotinylated mAb CMRF-44 (immunoglobulin M [IgM]), CMRF-75 (IgM), CD14 (CMRF-31, IgG2a), and IgG2a (isotype control) produced in our laboratory; CD3 (OKT3, IgG2a, American Type Culture Collection, Rockville, MD); CD16 (HuNK2, IgG2a) and CD19 (FMC63, IgG1), gifts from Prof H. Zola, Adelaide, Australia; PE-conjugated IgG2a (isotype control), IgG2b (isotype control), CD86 (24F, IgG1), and CD123 (9F5, IgG2b), (PharMingen International, San Diego, CA); PE-conjugated CD3 (SK7, IgG1), CD4 (SK3, IgG1), CD11c (S-HCL-3, IgG2a), CD14 (leuM3, IgG2b), CD16 (leu11c, IgG1), CD19 (leuM12, IgG1), CD80 (L307.4, IgG1), and HLA-DR (L243, IgG2a) (Becton Dickinson); CD83 (HB15a, IgG2b, Immunotech, Marseille, France); FITC-conjugated HLA-DR (MCA672F, IgG1, Serotec, Oxford, United Kingdom); PE-cyanin 5-conjugated IgG1 (PharMingen); and HLA-DR (Immu375, IgG1, Immunotech).The following reagents were used: FITC-SAM (Amrad Biotech, Melbourne, Australia); PE-cyanin 5-conjugated streptavidin (Dako, Carpinteria, CA); mouse serum and PI (Sigma, St Louis, MO); RPMI 1640 and fetal calf serum (Life Technologies, Melbourne, Australia); and water-soluble hydrocortisone (Pharmacia and Upjohn, Sydney, Australia). Statistical analysis Changes in absolute and percentage DC count triplicates between measurement times were analyzed using a hierarchic linear model using the Mixed procedure in SAS software (SAS Institute, Cary, NC).15 Within the model, the intercept and time effects are treated as both fixed and random effects.
Blood DC counting method in normal individuals using CMRF-44 mAb The CMRF-44+ DCs as measured in this method are HLA-DR++, CD4+, CD40+, CD80+, CD83+, and CD86+. They include cells from the 2 DC subsets (CD11c+CD123dim/ and
CD11c CD123+) (Figure 1B).
The CMRF-44 mAb was used to establish a flow cytometry-based DC
counting method and to define an adult normal range
elsewhere.9 Using this method, we obtained a new normal
range from 56 healthy adults drawn from hospital, laboratory staff, and
the general public. The mean DC count and DC percentages were
13.6 × 106/L (± 6.6 × 106/L [SD],
range 2.8 × 106 to 29.0 × 106/L) and
0.56% (± 0.28% [SD], range 0.14% to 1.29%), respectively (Figure 2A). These results were similar
to those obtained previously9 and verify the
reproducibility of the method. Intraindividual variation was assessed
by performing serial DC counts on 3 healthy volunteers on 8 separate
occasions over a period of 5 months. Samples were drawn during the same
time each morning on each occasion. Although some intraindividual
variation in DC count is observed, the counts tend to cluster together
to reflect the overall baseline normal level for each individual
(Figure 2B). When counts of other MNC populations (lymphocytes and
monocytes) were analyzed, similar variations were also observed for
each individual (Figure 2B).
Blood DC counts are altered by surgical and exercise stress Serial DC counts were performed on patients undergoing elective laparoscopic cholecystectomy. DC counts rose in all but one patient, peaking either during surgery (IntraOp) in 15 (58%) patients, immediately after (Recovery) in 6 (23%) patients, or on day 1 after surgery in 4 (15%) patients. The mean DC count recorded a significant rise (P = .0001) from 16.0 × 106/L (± 1.7 × 106/L [SEM]) at PreOp to 27.0 × 106/L (± 3.7 × 106/L [SEM]) at IntraOp (Figure 3A, line graph, left axis). The change in DC counts (106/L) was closely reflected in the DC numbers as a percentage of MNCs (Figure 3A, column, right axis). The DC counts were observed to be lowest in the day 2-3 time point (P = .05, Figure 3A). A small (statistically nonsignificant) increase in DC counts was detected in the control group, possibly reflecting a circadian variation (Figure 3B).
To compare the effect of another type of stress in the form of exercise, we monitored the DC counts in healthy volunteers who undertook the treadmill exercise program according to the Bruce protocol. All subjects reached stage 5 of the protocol and achieved their maximum predicted heart rate prior to completing the exercise. A rise in the blood DC count (106/L) measured immediately after the exercise was observed in all subjects. The mean DC count at the peak was 22.0 × 106/L (± 4.2 × 106/L [SEM], P = .0004; Figure 3C, line, left axis). Two hours after the cessation of exercise, the DC counts returned to baseline levels. Interestingly, the DC proportion (ie, percentage of MNCs) did not rise (Figure 3C, column, right axis). In six individuals, Lin
Blood DC counts change independently of monocyte counts during surgical stress but not exercise To compare the changes between DC, monocyte, and lymphocyte counts, we expressed the changes as a percentage change normalized to the PreOp counts. The mean percentage IntraOp rise in blood DCs was 71.7% ± 11% (SEM) (Figure 5A), and it fell 25% ± 14% (SEM) below PreOp values on days 2-3. DC counts in control individuals showed a small rise over the matched time course, which may reflect a circadian change, but the rise in surgical patients was significantly greater than in the controls (P < .05; Figure 5A). Blood DC counts were increased 100% ± 10% (SEM) immediately after exercise compared with the PreEx value (Figure 5D).
Monocyte counts (measured by the clinical automated counter) peaked at 57% ± 15% (SEM) above baseline levels on day 1, at a time when DC counts had already normalized levels (Figure 5B). Similar results were obtained using a CD14 mAb flow cytometry technique (data not shown). In healthy individuals, monocyte counts showed minimal changes over the matched time course. In comparison, exercise induced a greater (74% ± 22% [SEM]) rise, but in contrast to surgery, the rise paralleled the rise in DC counts (Figure 5E). Total lymphocyte counts (measured by the clinical automated counter) rose by 48% ± 7% (SEM) during surgery, coincidental with the rise in blood DCs (Figure 5C). In healthy individuals, lymphocyte counts also showed a rise over the matched time course. Exercise also induced a concomitant rise of 175% ± 14% (SEM), greater in lymphocyte count than that seen in surgery (Figure 5F). Blood DC activation molecules are not induced by surgical stress or exercise in vivo Cytokines, such as IL-1 , tumor necrosis factor- , and IL-6,
released during surgery are known to induce the in vitro up-regulation of the CD40, CD80, and CD86 molecules on blood DCs; therefore, we
investigated the activation status of fresh blood DCs. The CMRF-44
antigen is rapidly up-regulated on DCs in vitro without added
activation stimuli; however, negligible CMRF-44+ DCs were
identified in fresh MNCs during surgery (Figure
6). A proportion of fresh
Lin HLA-DR+ DCs from blood collected PreOp
expressed CD40 and CD86, but no further up-regulation of either of
these molecules occurred during surgery (Figure 6). No up-regulation of
CMRF-44, CD40, and CD86 expression was noted during exercise.
Blood DC subsets and allostimulatory function are not altered by surgery or exercise The Lin HLA-DR+ DCs were also analyzed
to determine the proportion of CD11c+ and
CD11c subsets. The percentage of CD11c+ and,
conversely, CD11c (predominantly CD123+) DCs
remained stable during surgery (n = 8) and exercise (n = 2) (Table
1). The percentage of CD123+
DCs was more variable, 2 rising, 3 falling, and 1 constant in surgery
(PreOp = 28.8 ± 8.0 [SEM], IntraOp = 23.9 ± 7.1, Recovery = 32.5 ± 7.8, n = 6). The rise in DC counts observed during
surgery did not result in an obvious increase in the ability of the
MNCs to stimulate a MLR.
The rise in blood DC count correlates with serum cortisol levels in surgical stress and exercise The mean normalized IntraOp serum cortisol increased to 140% ± 50% (SEM) and peaked in Recovery (238% ± 48% [SEM]) before falling to near baseline levels one day after surgery. However, the stress of exercise induced a rise in serum cortisol levels in 2 of 5 individuals, which peaked 2 hours after cessation of exercise. In both situations, the peak serum cortisol occurred after the peak DC counts.Pharmacologic steroid administration may influence DC
function.16 To determine if stress corticosteroid levels
influenced the expression of CMRF-44 and hence the enumeration of blood
DCs in stress situations, the effect of hydrocortisone on CMRF-44 expression of DCs was tested in blood samples obtained from healthy individuals. A 2-hour preincubation period with hydrocortisone (10
We report here the first "routine" application of a method to
enumerate circulating DCs in a group of patients undergoing routine
surgery in a standard clinical setting. We document a rapid surgical
stress-induced rise in blood DC counts and make the important
physiologic observation that this in vivo rise is independent of
monocyte counts, the cell suggested to be an in vitro precursor of DCs.
Studies on physical exercise were also instructive DC counts rose early in surgery, and this was followed by a temporary depression of postoperative DC counts. This depression was limited in this relatively minor surgery but may prove more significant in major surgery. Two patients had their laparoscopic surgery converted to open cholecystectomy, where their blood DC counts peaked at 31 × 106/L and 29.6 × 106/L and fell to a nadir of 6.9 × 106/L and 3.2 × 106/L, respectively. The former had a persistently low DC count, ranging from 2.9 × 106 to 6.9 × 106/L during a 3-week follow-up period. The patient subsequently developed a chest infection and was treated with intravenous antibiotics in the hospital for 2 days, and only at week 16 did the follow-up DC count return to the preoperative level. The magnitude of the serum cortisol increases in our patients confirmed a significant stress response to surgery comparable to earlier reports.17 The well-documented effects of glucocorticoids on the immune system may be attributed to the immunosuppression seen after surgery and injury.4 The alterations in blood DC numbers after surgery may be a highly relevant factor to consider in analyzing postoperative infection risk. DCs require defined signals to induce their differentiation and activation.2 We anticipated that the variety of inflammatory mediators released during surgery might lead to DC activation. Curiously, we found no in vivo up-regulation of the sensitive DC activation CMRF-44 antigen on fresh DCs. Similarly, no up-regulation of CD40 or CD86 was observed. This suggests that although circulating DC numbers are increased, possibly to supply damaged peripheral sites with DCs, these cells remain tightly regulated in terms of their costimulatory capacity while in circulation. This may reflect one of the mechanisms for maintaining self-tolerance and is consistent with the hypothesis that DCs are activated in peripheral tissues upon contact with the right signals and undergo further maturation as they migrate to the lymph nodes.2 The rapid increase in blood DCs during surgery suggests they are preformed and mobilized from existing "storage" sites. Inflammatory cytokines and hormones released during surgery and exercise may contribute to this phenomenon.7,8,18 There is no evidence yet to suggest blood DCs are marginated on blood vessels, but the splanchnic vasculature (including the spleen and liver) or possibly the bone marrow may be sources. DC mobilization from the tissues is unlikely, because these traffic to lymph nodes. Despite the rise in DCs during surgery, we did not observe an obvious change in the ability of the MNCs to stimulate proliferation in the MLR. This is most likely to be due to the lack of sensitivity of the MLR assay or the result of other cell types in limiting the action of DCs. Exercise induces a significant and reproducible increase in DC count, and the mediators involved may be of interest as potential mobilizers of DCs for immunotherapeutic programs. Interestingly, although the stress of surgery and exercise cannot be directly compared, similar changes on immunologic and endocrine parameters have been documented.7,18 The consistent rise in the CD11c+ DC subset (and parallel but individually inconsistent changes in CD123+ subset) in surgery contrasts with the significant changes in DC subsets observed in other situations11 (S.V., unpublished data, June 2000). The ontogenic relationship between DCs and monocytes has been a long-standing issue and remains unresolved. Data reported here and elsewhere19 suggest that blood DC and monocyte levels are regulated differently depending on the physiologic circumstances. However, it is notable that the DC counts rise in a coordinated fashion with lymphocytes and, at face value, this might be interpreted as a coordinated production/mobilization of these 2 key interacting components of a cognate immune response. In summary, we have validated a new test for counting blood DCs and have shown that these vital cells increase in number as part of the acute response to surgical and physical stress response. Our additional experience with the method suggests valuable clinical data will be obtained by studying other patient groups, and interesting differences are already being observed. The availability of this routine method to monitor blood DC numbers may open a new window in our understanding of the immune system and has the potential to assist the management of patients. DC counts may, for example, have prognostic value after surgery or infection. Blood DC counts will certainly facilitate the planning of any DC immunotherapy protocols.
We thank the patients and volunteers who participated in the study and thank our surgical colleagues for their contribution. We thank Dalia Khalil and Len Brown for technical support on the flow cytometer. We are grateful to Dr Maria Gilleece for critical reading of the manuscript and Tracy Heywood for help in preparing this manuscript. We especially acknowledge the assistance of Sullivan Nicolaides Pathology, Queensland, Australia, for the out-of-hospital collection of patient specimens.
Submitted September 22, 2000; accepted February 28, 2001.
Supported by a Mater Medical Research Institute grant. C.S.K.H. supported by the HIH Winterthur-Raelene Boyle Scholarship from the Royal Australasian College of Surgeons.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Derek N. J. Hart, Mater Medical Research Institute, Aubigny Place, Raymond Terrace, South Brisbane, Qld 4101, Australia; e-mail: dhart{at}mmri.mater.org.au.
1. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811[CrossRef][Medline] [Order article via Infotrieve].
2.
Hart DNJ.
Dendritic cells: unique leucocyte populations which control the primary immune response.
Blood.
1997;90:3245-3287 3. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5:1249-1255[CrossRef][Medline] [Order article via Infotrieve].
4.
Walton B.
Effects of anaesthesia and surgery on immune status.
Br J Anaesth.
1979;51:37-43 5. Angele MK, Knoferl MW, Ayala A, et al. Trauma-hemorrhage delays wound healing potentially by increasing pro-inflammatory cytokines at the wound site. Surgery. 1999;126:279-285[Medline] [Order article via Infotrieve]. 6. Toft P, Tonnesen E, Helbo-Hansen HS, Lillevang ST, Rasmussen JW, Christensen NJ. Redistribution of granulocytes in patients after major surgical stress. APMIS. 1994;102:43-48[Medline] [Order article via Infotrieve].
7.
DeRijk R, Michelson D, Karp B, et al.
Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6.
J Clin Endocrinol Metab.
1997;82:2182-2191 8. Bury TB, Louis R, Radermecker MF, Pirnay F. Blood mononuclear cells mobilization and cytokines secretion during prolonged exercises. Int J Sports Med. 1996;17:156-160[Medline] [Order article via Infotrieve].
9.
Fearnley DB, Whyte LF, Carnoutsos SA, Cook AH, Hart DNJ.
The monitoring of human blood dendritic cell numbers: preliminary clinical results in stem cell transplants.
Blood.
1999;93:728-736
10.
Rissoan M, Soumelis V, Kadowaki N, et al.
Reciprocal control of T helper cell and dendritic cell differentiation.
Science.
1999;283:1183-1186
11.
Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C.
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
Blood.
2000;95:2484-2490 12. Hock BD, Starling GC, Daniel PB, Hart DNJ. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology. 1994;83:573-581[Medline] [Order article via Infotrieve].
13.
Fearnley DB, McLellan AD, Mannering SI, Hock BD, Hart DNJ.
Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen presenting cell function and immunotherapy.
Blood.
1997;89:3708-3716 14. Lazarus M, Dang TY, Gardin JM, Allfie A, Henry WL. Evaluation of age, gender, heart rate and blood pressure changes and exercise conditioning on Doppler measured aortic blood flow acceleration and velocity during upright treadmill testing. Am J Cardiol. 1988;62:439-443[CrossRef][Medline] [Order article via Infotrieve]. 15. Singer JD. Using SAS PROC MIXED to fit multilevel, hierarchical models and individual growth models. J Educ Behav Stat. 1998;24:323-355. 16. Lim TK, Chen GH, McDonald RA, Toews GB. Granulocyte-macrophage colony-stimulating factor overrides the immunosuppressive function of corticosteroids on rat pulmonary dendritic cells. Stem Cells. 1996;14:292-299[Abstract].
17.
Redmond HP, Watson RW, Houghton T, Condron C, Watson RG, Bouchier-Hayes D.
Immune function in patients undergoing open vs laparoscopic cholecystectomy.
Arch Surg.
1994;129:1240-1246 18. Vittimberga FJ Jr, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg. 1998;227:326-334[CrossRef][Medline] [Order article via Infotrieve]. 19. Vuckovic S, Fearnley DB, Gunningham SP, et al. Dendritic cells in chronic myelomonocytic leukaemia. Br J Haematol. 1999;105:974-985[CrossRef][Medline] [Order article via Infotrieve].
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
M. Okutsu, Y. Yoshida, X. Zhang, A. Tamagawa, T. Ohkubo, I. Tsuji, and R. Nagatomi Exercise training enhances in vivo tuberculosis purified protein derivative response in the elderly J Appl Physiol, June 1, 2008; 104(6): 1690 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Smolewska, J Stanczyk, H Brozik, M Biernacka-Zielinska, B Cebula, T Robak, and P Smolewski Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis Ann Rheum Dis, June 1, 2008; 67(6): 762 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Diao, E. Winter, C. Cantin, W. Chen, L. Xu, D. Kelvin, J. Phillips, and M. S. Cattral In Situ Replication of Immediate Dendritic Cell (DC) Precursors Contributes to Conventional DC Homeostasis in Lymphoid Tissue. J. Immunol., June 15, 2006; 176(12): 7196 - 7206. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Smith, R. L. Gamelli, S. B. Jones, and R. Shankar Immunologic Responses to Critical Injury and Sepsis J Intensive Care Med, May 1, 2006; 21(3): 160 - 172. [Abstract] [PDF] |
||||
![]() |
P. Athanassopoulos, L. M.B. Vaessen, A. H.M.M. Balk, J. J.M. Takkenberg, A. P.W.M. Maat, W. Weimar, and A. J.J.C. Bogers Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saint-Mezard, C. Chavagnac, S. Bosset, M. Ionescu, E. Peyron, D. Kaiserlian, J.-F. Nicolas, and F. Berard Psychological Stress Exerts an Adjuvant Effect on Skin Dendritic Cell Functions In Vivo J. Immunol., October 15, 2003; 171(8): 4073 - 4080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vuckovic, M. Kim, D. Khalil, C. J. Turtle, G. V. Crosbie, N. Williams, L. Brown, K. Williams, C. Kelly, P. Stravos, et al. Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression Blood, March 15, 2003; 101(6): 2314 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. A. MacDonald, D. J. Munster, G. J. Clark, A. Dzionek, J. Schmitz, and D. N. J. Hart Characterization of human blood dendritic cell subsets Blood, December 15, 2002; 100(13): 4512 - 4520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osugi, S. Vuckovic, and D. N. J. Hart Myeloid blood CD11c+ dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes Blood, September 26, 2002; 100(8): 2858 - 2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Kantarjian, S. O'Brien, J. E. Cortes, S. A. Giralt, M. B. Rios, J. Shan, F. J. Giles, D. A. Thomas, S. Faderl, M. De Lima, et al. Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia Blood, August 13, 2002; 100(5): 1590 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. K. Ho, D. Munster, C. M. Pyke, D. N. J. Hart, and J. A. Lopez Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines Blood, April 15, 2002; 99(8): 2897 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Febbraio, R. L. Starkie, S. G. Rhind, and P. N. Shek The Cellular Origin of Plasma Cytokine Expression After Acute Exercise Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1253 - R1257. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||